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ABSTRACT 
 
     Menorrhagia is one of the most common gynecological problem and leading causes of poor quality of life 
and iron deficiency anemia in women of reproductive age. Research in gynecological field relies heavily on 
repeated measure designs. Repeated measure studies are helpful in understanding how factors of interest 
change over time. Our goal is to apply statistical methods which are appropriate for analyzing repeated 
measure data such as gynecological data. Three statistical methods were performed by data collection from 
100 patients with menorrhagia. One-hundred patients were randomly assigned to two groups, i.e. 
intervention group (Urtica Dioica and mefenamic acid) and control group (placebo and mefenamic acid) 
with an equal size of 50. In this study, generalized estimating equations (GEE) and mixed effects models 
(MEM) were used for analyzing menorrhagia data to determine the effect of hydroalcoholic extract of Urtica 
Dioica on Menorrhagia. Finally, these methods are compared to the conventional repeated measures 
ANOVA (RM-ANOVA). 
Based on the results, the three methods are found to be similar in terms of statistical estimation, the amount 
of bleeding before and after treatment between and within groups was compared. Results showed the 
average amount of bleeding was reduced significantly (P˂0/001). The average menorrhagia score in the third 
month (second cycles after intervention) were 91.38(71.432) and 149.40(127.823) in Urtica Dioica and 
control groups, respectively. The difference between the two groups was statistically significant (p =0.036). 
Because their advantages, GEE and MEM should be strongly considered for the analysis of repeated 
measure data. In particular, GEE should be utilized to explore overall average effects. When in addition to 
overall average effects, subject-specific effects are of primary interest, MEM should be utilized. With 
respect to these methods, it seems the extract of Urtica Dioica can be effective in reducing the amount of 
menstrual bleeding in women of reproductive age with Menorrhagia. 
 
Keywords: Repeated Measure-ANOVA; Generalized Estimating Equations; Mixed Effects Models; 
Repeated measure study; Menorrhagia 
 
INTRODUCTION 
     Menorrhagia is an abnormally heavy and 
prolonged menstrual period at irregular intervals 
and is an important cause of ill health in women. 
A normal menstrual cycle is 21–35 days in 
duration, with bleeding lasting an average of 5 
days and total blood flow between 25 and 80 
mL. A blood loss of greater than 80 mL or 
lasting longer than 7 days constitutes 
menorrhagia[1]. It is one of the most common 
gynecological problem[2] and leading causes of 
poor quality of life and iron deficiency anemia 
in women of reproductive age[3]. More than 30 
percent of women of reproductive age and 60 
percent of the total female population experience 
menorrhagia [2] and  44.7 % of Iranian girl 
experience it, too[4]. Often the bleeding is 
severe enough to adversely affect the patient’s 
social, physical, and emotional well-being[5]. 
Menorrhagia accounts for about 25% of all 
gynecological surgeries[6]. It described as 
excessive uterine bleeding, affects 
 




approximately 10 million American women 
annually, most of whom are in their 40’s and 
50’s and accounts for 20% of visits to 
gynecologists[7]. It reduces quality of life and 
caused Discomfort and anxiety [2, 8-10]. 
In recent year, medical treatment, surgical and 
pharmaceutical plants have been used for the 
treatment of menorrhagia. It seems, the extract 
of Urtica Dioica can be effective in reducing the 
amount and duration of menstrual bleeding in 
women of reproductive age with menorrhagia. 
In this study, we consider a two-group 
comparative (i.e. treatment vs. control) Repeated 
measure or longitudinal study (LS) in clinical 
example. 
Here we use a two-group design but statistical 
inferences can be generalized for different 
number of groups. 
LS design, involving consecutive measurements 
on the same individual, has become popular for 
examining trends in outcomes over time. 
Compared to a cross-sectional study, which 
assesses the outcome at a single point in time, 
repeated measure study can provide information 
about changes in both individual and average 
group outcomes over time. Several factors need 
to be considered in the statistical analysis of 
repeated measures data. The measurements 
obtained from an individual at a particular point 
in time are correlated with the measurements 
obtained at prior time point(s) and this 
dependence needs to be taken into account in the 
analysis.  Often, these data contain missing 
values due to loss to follow up or other reasons, 
such as the participant being unavailable to have 
the outcome measured at some time point(s). 
These missing data result in information from 
different individuals available at different time 
points, that is, an unbalanced design and also 
existence of multiple covariates. If these 
complexities are properly addressed, a LS has 
the advantage of being able to answer important 
and clinically  questions with higher precision 
than a study with simpler design[11]. 
All of these factors have resulted in the growing 
popularity of repeated measure design and have 
become important reasons for the development 
of new statistical methods during the past few 
decades. The relatively new and more advanced 
methods of Generalized Estimating Equations 
(GEE) [12] and Mixed Effects Models (MEM) 
[13] have started to replace the traditional 
methods of Repeated Measures ANalysis Of 
VAriance (RM-ANOVA) [14] and t-test, as the 
older methods are not flexible enough to 
accommodate all of features of repeated measure  
designs. Repeated measure studies are 
particularly important in the field of 
gynecological research. 
Therefore, in this manuscript, we apply RM-
ANOVA, GEE, and MEM in simple terms for 
analyzing data from a clinical study with 
continuous outcome and compare the results 
from each method.  
The research questions we focus on are: Is there 
an improvement in the menorrhagia over time in 
the group that received Urtica Dioica?  
We selected the menorrhagia as our continuous 
outcome measure, which was derived from the 
Pictorial Blood Loss Assessment Chart 
(PBLAC) [15]. 
A randomized triple blinded clinical trial was 
carried out on 100 women affected by 
menorrhagia, selected by convenience sampling, 
which had inclusion criteria. Data collection 
tools were data form, weight, meter and PLBAC 
chart. Measurements from 100 women were 
taken at three month so that, first month is 
before intervention, second and third month are 
first and second cycles after intervention, 
respectively. 
 
MATERIALS AND METHODS 
     In this paper, we consider a two-group 
comparative (i.e. Urtica Dioica vs. control) 
repeated measure design in clinical example. 
Although here we use a two-group design, 
statistical inferences can be generalized for 
repeated measure design involving a different 
number of groups. 
Assessing the change in outcome measure over 
time 
     Figures show that means of the menorrhagia 
scores at each time point across all individuals.  
For repeated outcome measures where the 
individual measurements are correlated, the 
visualization of means and confidence intervals 
at different time points does not provide an 
adequate representation of the change in the 
 




outcome over time within individuals. The 
within-individual variation in repeated outcome 
measures can be explored by joining the 
measurements of the same individual over time. 
Figure 1, commonly known as a spaghetti plot, 
shows individual trajectories along with 
superimposed means of the menorrhagia scores at 
each time point for the two groups. For the purpose 
of illustration, in Figure 1, we have included 
trajectories of all participants from the study. 
The change in menorrhagia scores over time 
seems to differ substantially between the two 
groups. For Urtica Dioica group, variability 
across time points seems to decrease relative to 
control group, this shows Urtica Dioica is 




Figure 1. Spaghetti plot showing individual trajectories of the menorrhagia scores for two groups Urtica Dioica and Placebo 
 
Conceiving correlations of the outcome measure 
between time points 
     Scatter plots [16] of the outcome measure 
assessed at one time point versus the outcome 
measured at another time point (e.g. 
menorrhagia score at first month vs menorrhagia 
score at second month) allow exploration of the 
within-individual correlation between the 




correlations of the menorrhagia scores among 
the three month of assessment for the two 
groups are shown in Figure 2. There seems to be 
strong correlations between the assessments, and 
these correlations do not systematically increase 
or decrease with the time lag between the 
assessments. 
 








Statistical Analysis of the Data 
Repeated Measures ANOVA 
     RM-ANOVA relates the study outcome 
variable to a set of covariates (e.g. treatment 
group, time) and compares the mean outcome at 
multiple time points or between groups. 
Although RM-ANOVA (one of the earliest 
proposed methods for analyzing correlated 
responses) has gained widespread popularity, it 
has several unattractive features. However, the 
weaknesses of this method for analyzing 
repeated measure  data are well documented in 
the literature [17, 18]. First, RM ANOVA 
requires the outcome variable to be quantitative 
(i.e. a continuous variable) and normally 
distributed. It also requires the covariates to be 
discrete (i.e. categorical variables). Second, RM-
ANOVA requires that the outcome have 
constant variance across time points as well as 
constant correlation between any two time 
points (i.e. assumption of sphericity). The 
assumption of constant correlation of repeated 
measures is often unrealistic in medical research 
as repeated measures often become less 
correlated with increasing time from treatment. 
This kind of violation of the sphericity 
assumption may cause inflated Type I error[19]. 
Third, RM-ANOVA can only handle repeated 
measure studies in which all subjects have the 
same numbers of repeated measurements. 
Specifically, RM-ANOVA excludes those 
subjects who have missing observations at one 
or more time points. Inclusion of only those 
subjects who have complete data for all 
variables has unfavorable subsequences. The 
group of subjects with complete data may not 
represent a random sample from the target 
population, thus causing biased results.  
Generalized estimating equations (GEE) 
     The GEE method focuses on average changes 
in response over time and the impact of 
covariates on these changes. The method models 
the mean response as a linear function of 
covariates of interest via a transformation or link 
function. To accommodate various types of 
outcomes that are not necessarily normally 
distributed, different link functions are 
employed for modeling the relationship between 
outcome and covariates. For example, an 
identity link function is used for a continuous 
outcome, a logit link function for a binary 
outcome and a log link function for count 
data[20]. These transformations can be 
considered repeated measures analogs of linear 
regression, logistic regression, and Poisson 
regression, respectively. GEE allows 
specification of the correlation structure from a 
wide variety of choices to account for variation 
in correlation between repeated measures. 
Popular choices, among others, include the 
compound symmetry (CS) correlation structure 
and the autoregressive (AR(1)) correlation 
structure. The CS correlation structure assumes a 
common correlation for any pair of responses at 
different time points, while the AR correlation 
structure assumes that measurements closer in 
time have a higher correlation than those that are 
further apart. GEE also has attractive and robust 
property in parameter estimation. Unlike RM-
ANOVA, GEE does not require the outcome 
variable to have a particular distribution. This 
feature can greatly benefit studies in which data 
are skewed or the distribution of data is difficult 
to verify due to a small sample size. 
Mixed effects models (MEM) 
MEM describes how the response of the 
individual participant changes over time. It 
considers between-individual heterogeneity by 
adding random effects to a subset of covariates 
of interest. These added random effects allow 
covariate coefficients to vary randomly from one 
individual to another, thereby providing an 
individual response trajectory over time. The 
most common MEM in repeated measure studies 
are those with random effects attached to 
baseline values or time dependent variables 
reflecting heterogeneity among individual 
responses at baseline or variation between 
individual trajectories over time. In addition, 
like GEE, MEM allows specification of the 
correlation structure between repeated 
measurements from similar choices such as the 
CS and AR(1). 
Clinical data analysis 
     Study [21] was conducted to determine the 
effect of hydroalcoholic extract of Urtica Dioica 
on menorrhagia among students of Babol Azad 
University 2012-13. 
A randomized triple blinded clinical trial was 
carried out on 100 women affected by 
 




menorrhagia, selected by convenience sampling, 
which had inclusion criteria. Data collection tools 
were data form, weight, meter and PLBAC chart. 
All samples after a control cycle of primary 
bleeding and dividing with random allocation to 
trial or control group were subjected to mefenamic 
acid treatment (500 mg every 8 hours) and Urtica 
Dioica 5 cap. Per day, from first to end of bleeding, 
up to 7 days, for two consecutive cycles, for trial 
group and for the control group, mefenamic acid 
and placebo as the same way of trial group, was 
prescribed. 
Menorrhagia was measured at first, second and third 
month postoperatively. Menorrhagia will be used as 
the continuous outcome. 
This data provides an illustration of repeated 
measure data analysis for menorrhagia.  
For illustrative purposes time, treatment group and 
the interaction between time and treatment were 
included in the models. All statistical analyses 
were performed in SAS software version 
9.2(SAS Institute, Cary, NC), R 2.14.0 and 
SPSS (version 21; SPSS, Chicago, IL, USA). 
“This research has been approved by Shahid 
Beheshti University of Medical Sciences's 
Medical Ethics Committee ( Referred 
Code:  201111254529N3)" 
 
RESULTS 
     The demographic and fertility characteristics 
of the study population are shown in Table 1. 
The average of age, BMI, Menarche age and 
Number of childbirth were not significant 
between control and Urtica Dioica group, so 
respect to the factors mentioned above, the two 
groups were matched.  
 
 
Table 1. Demographic and fertility characteristics of the study population    
 
Variable Control group(n=50) 
Mean(SD) 
Urtica Dioica group(n=50) 
Mean(SD) 
P-value 
Age 26.71(7.25) 25.24 (6.75) 0.324 
BMI 23.36 (3.30) 22.36 (2.94) 0.228 
Menarche age 13.33 (1.39) 13.53 (1.40) 0.546 
Number of 
childbirth 
0.56 (0.81) 0.29 (0.58) 0.092 
 
The average of menorrhagia score in the third 
month (second cycles after intervention) was 
91.38(71.432) and 149.40(127.823) in Urtica  
 
 
Dioica and control groups, respectively. The 
difference between the two groups was 
statistically significant (p =0.036), results are 
shown in table2. 
 
Table 2 .Menorrhagia score of study population before intervention (first month) and after intervention (second and third month) 
 





First month 303.98 (213.839) 315.16 (191.498) 0.412 
Second month 149.51 (115.381) 113.07 ( 62. 798) 0.182 
Third month 149.40 (127.823) 91.38 (71. 432) 0.036 
The obtained results showed that the amount of 
bleeding reduced significantly in both groups 
after treatment, the reduction of bleeding amount    
in the Urtica Dioica group was significantly 
higher than that in the control group that figure 3 
shows this, too. 
 





Figure 3. Mean of menorrhagia scores for two groups Urtica Dioica and Placebo at first month (before intervention), second 
month (first cycle after intervention) and third month (second cycle after intervention) 
 
Table 3 reports the findings from all three 
methods in treatment effect, time effect and 
interaction effect of treatment and time. All 
three methods showed similar result, time, 
treatment and interaction term were significant.
 





















Significancy the interaction between time and 
treatment showed that Urtica Dioica can be 
effective in reducing the amount of menstrual 
bleeding in women of reproductive age with 
menorrhagia. 
  RM-ANOVA   
Effect Treatment Time Treatment× Time 
P-value <0.001 <0.001 <0.001  
  MEM   
Effect Treatment Time Treatment× Time 
Parameter Estimate 
 
0.4 -0.41 -0.26  
 
 
Standard error 0.15 0.05 0.08  
P-value 0.0098 <0.0001 0.0011  
  GEE   
Effect Treatment Time Treatment× Time 
Parameter 0.39 -0.41 -0.26  
Standard error 0.16 0.04 0.07  
P-value 0.0178 <0.0001 0.0003  
 




GEE and MEM produced similar parameter 
estimates and both had population-averaged 
interpretations. For example, average increases 
of 0.13 (0.39-0.26) mL and 0.14 (0.4-0.26) mL 
menorrhagia in the treatment group compared to 
the control group, respectively, were identified 
using GEE and MEM. 
While GEE and MEM estimates the magnitude 
of these effects and tests their significances, 
RM-ANOVA only assesses significance. The 
reported MEM has random effects attached to 
baseline Menorrhagia and time in order to 
consider the between-patient variations. The 
assumption of sphericity in RMANOVA is 
violated (p<0.001), showing non-constant 
variances and correlations over time. 
The AR(1) correlation structure is specified in 
GEE and MEM to provide a more pragmatic 
modeling strategy. 
DISCUSSION  
     Through the application of the three methods, 
we were able to show that GEE and MEM are 
more flexible than RM-ANOVA for 
investigating continuous outcomes and modeling 
a variety of correlation patterns between 
repeated measures. There are other important 
differences among the three approaches. 
Besides the noted differences, the three methods 
were used to answer different research 
questions. With data collected from every 
individual at every time point, we wanted to 
make statistical inferences regarding the change 
in mean response over time (a population 
averaged inference) or the individual trajectory 
over time (a subject-specific inference). Both 
RM-ANOVA and GEE measured population-
averaged effects of covariates of interest. MEM 
by contrast, could identify subject-specific 
effects of covariates on the changes in the 
response over time. Therefore, MEM would be 
helpful where an intervention is likely to affect 
some individuals differently than others as 
compared to RM-ANOVA and GEE which do 
not take individual response into account in their 
interpretations. MEM could allow for a more 
various analysis of individuals of this sub-
population such as predicting individual risk of 
complications. 
Yan and et.al in their study compared GEE, 
MEM and RM-ANOVA through study 
conducted in the Department of Anesthesiology 
at the Hospital for Special Surgery to assess 
limb preconditioning on reduction pain. They 
provided an illustration of longitudinal data 
analysis for C-reactive protein (CRP) as a 
continuous outcome[11]. 
Cleophas and et.al reviewed Methods for 
analyzing cardiovascular studies with repeated 
measures. They compared MEM with RM-
ANOVA [22]. 
Livera and et.al using data collected from a trial 
evaluating an intervention for managing asthma 
and chronic obstructive pulmonary disease, 
demonstrated ways of statistically analyzing 
repeated measures data. They applied MEM and 
RM-ANOVA [16]. 
The purpose of this paper was to present 
methods to consider the special nature of 
repeated measures data in assess the effect of 
Urtica Dioica in reducing the amount of 
bleeding in women of reproductive age with 
heavy menstrual bleeding. This drug, due to its 
short course of prescription, fewer side effects 
and not having hormonal effects, seems to be an 
effective drug for treating heavy menstrual 
bleeding. It is a well known ethnomedicinal 
plant and in most parts of the world is used to 
treat various diseases, it includes different 
chemical products, such as caffeic malic acid, 
Polysaccharides, Lectin, Agglutinin, Scopoletin, 
Serotonin and D, C and K vitamins [23, 24]. 
Farahmand and et.al in their study showed that 
both vitamin E and Ibuprofen reduces bleeding 
amount in primary dysmenorrheal and does not 
cause any digestive disorder or fatigue [25]. 
Rahnama and et.al showed  that ginger may be 
an effective and safe therapy for relieving pain 
in women with primary dysmenorrhoea if 
administered at the onset or during the 3 days 
prior to menstruation[26]. 
Safari and et.al indicated both vitamin E and 
mefenamic acid could reduce the amount of 
bleeding similarly, nevertheless complications of 
vitamin E consumption, such as digestive 
disorders like, aspyrosis, stomach-ache, nausea 
and fatigue were significantly less compared to 
mefenamic acid [27]. 
 




Most of results from other studies were 
comparable to our results. Obtained results from 
this study, showed that the extract of Urtica 
Dioica can be effective in reducing the amount 
of menstrual bleeding but difference between 
two groups at second month weren’t statistically 
significant. Maybe, one reason for the lack of 
significance between the two groups was short 
follow-up period and consumption Urtica Dioica 
over a short period of time (only two month), so 
for Achieving more accurate results, study with 
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